Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis
- Nat Genet. 2014 Jan;46(1):61-64. doi: 10.1038/ng.2826.
- 1. Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
- 2. Genomic Regulation of Pancreatic Beta-Cells Laboratory, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Spain.
- 3. CIBER de Diabetes y Enfermedades Metabólicas, 08036 Barcelona, Spain.
- 4. Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE)-Consejo Nacional de Investigaciones Científicas y Técnicas, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.
- 5. Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Anne McLaren Laboratory for Regenerative Medicine, West Forvie Site, Robinson Way, Cambridge, UK.
- 6. Seattle Children's Hospital Research Institute, Seattle, WA 98101, USA.
- 7. School of Biomedical Science, Waterloo Campus, King's College London, London, UK.
- 8. London Centre for Paediatric Endocrinology and Metabolism, in partnership with the Great Ormond Street Hospital for Children National Health Service Trust, London, UK.
- 9. Institute of Child Health, University College London, London, UK.
- 10. Diabetes Research Group, Diabetes and Nutritional Sciences Division, School of Medicine, King's College London, London, UK.
- 11. Department of Medicine, Imperial College, London, UK.
- # Contributed equally.
The contribution of cis-regulatory mutations to human disease remains poorly understood. Whole-genome Sequencing can identify all noncoding variants, yet the discrimination of causal regulatory mutations represents a formidable challenge. We used epigenomic annotation in human embryonic stem cell (hESC)-derived pancreatic progenitor cells to guide the interpretation of whole-genome sequences from individuals with isolated pancreatic agenesis. This analysis uncovered six different recessive mutations in a previously uncharacterized ~400-bp sequence located 25 kb downstream of PTF1A (encoding pancreas-specific transcription factor 1a) in ten families with pancreatic agenesis. We show that this region acts as a developmental enhancer of PTF1A and that the mutations abolish enhancer activity. These mutations are the most common cause of isolated pancreatic agenesis. Integrating genome Sequencing and epigenomic annotation in a disease-relevant cell type can thus uncover new noncoding elements underlying human development and disease.